HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate Hikes Prices, Expects To Hit EPS Growth Target In 2011

This article was originally published in The Rose Sheet

Executive Summary

Colgate-Palmolive plans to raise prices on products across its portfolio and in all geographies, President and CEO Ian Cook told analysts April 28.

You may also be interested in...



Colgate Looks To Aging Gums, Whitening Launches For Growth In 2012

Colgate-Palmolive plans oral-care launches in 2012 aimed at aging consumers seeking gum protection as well as consumers looking for “a shinier, sparkling smile.” Firm reports fiscal 2011 sales of $16.7 billion, up 7.5% from the year prior.

Firms Inundated With Higher Costs, But New Market Trends Help Keep Them Afloat

Social media and green product trends could ultimately offset costs for personal care firms burdened with rising commodity and material prices, suggests a new report by Kline & Company. Report evaluated spending for 12 firms including Avon and Procter & Gamble.

Unilever Q1 Bolstered By Deodorant Sales; Price Increases Planned

Strong deodorant sales, especially in North America, helped drive Unilever PLC’s personal-care sales up 12.6% to €3.5 billion, or approximately $5.2 billion, for its fiscal 2011 first quarter ended March 31, the firm announced April 28.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel